Reducing errors in the management of hyperbilirubinaemia: validating a software application

Area of Science:

• Neonatal Medicine
• Clinical Informatics
• Medical Software Development

Background:

• Hyperbilirubinaemia is a common neonatal condition requiring careful management.
• The American Academy of Pediatrics (AAP) provides guidelines for managing hyperbilirubinaemia.
• Accurate application of these guidelines is crucial to prevent infant morbidity.

Purpose of the Study:

• To evaluate the utility and reliability of a novel software tool designed to assist in applying the 2004 AAP hyperbilirubinaemia guidelines.
• To assess the tool's impact on clinical decision-making accuracy and efficiency.

Main Methods:

• A randomized, cross-over, controlled trial was conducted using 20 simulated clinical cases.
• Fifteen physicians (residents and consultants) compared manual guideline application with software-assisted application.
• Outcomes measured included major errors, minor errors, and time spent on case management.

Main Results:

• The software tool significantly reduced both major and minor errors in hyperbilirubinaemia management.
• Minor errors decreased from 42 to 25, and major errors decreased from 10 to 2 with software use.
• Residents demonstrated the most improvement, making fewer errors and saving time, while consultant time savings were not significant.

Conclusions:

• Simulated cases highlighted frequent errors in routine hyperbilirubinaemia management.
• The developed software tool enhances clinical accuracy and efficiency, particularly for resident physicians.
• The software shows promise in improving adherence to clinical guidelines for neonatal jaundice.